Acadia Pharmaceuticals
ACAD
ACAD
186 hedge funds and large institutions have $1.79B invested in Acadia Pharmaceuticals in 2018 Q2 according to their latest regulatory filings, with 40 funds opening new positions, 63 increasing their positions, 59 reducing their positions, and 49 closing their positions.
Holders
186
Holders Change
-10
Holders Change %
-5.1%
% of All Funds
4.26%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.05%
New
40
Increased
63
Reduced
59
Closed
49
Calls
$47M
Puts
$39.6M
Net Calls
+$7.31M
Net Calls Change
+$36.5M
Top Buyers
1 |
1
BlackRock
New York
|
$149M |
2 |
GPP
2
Great Point Partners
Greenwich,
Connecticut
|
$30.5M |
3 |
3
State Street
Boston,
Massachusetts
|
$89M |
4 |
4
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
$33.4M |
5 |
O
5
OrbiMed
New York
|
$65.4M |